Cite
HARVARD Citation
Kavakli, K. et al. (n.d.). Prophylaxis vs. on‐demand treatment with BAY 81‐8973, a full‐length plasma protein‐free recombinant factor VIII product: results from a randomized trial (LEOPOLD II). Journal of thrombosis and haemostasis. pp. 360-369. [Online].